Karacay, Ceren
Prietl, Barbara
Harer, Clemens
Ehall, Barbara
Haudum, Christoph W.
Bounab, Kaddour
Franz, Joakim
Eisenberg, Tobias
Madeo, Frank
Kolb, Dagmar
Hingerl, Kerstin
Hausl, Markus
Magnes, Christoph
Mautner, Selma I.
Kotzbeck, Petra
Pieber, Thomas R.
Funding for this research was provided by:
BioTechMed-Graz (MIDAS-Inflammatory Mechanisms in Diabetes Uncovered by Tissue Imaging and Machine Learning, MIDAS-Inflammatory Mechanisms in Diabetes Uncovered by Tissue Imaging and Machine Learning, MIDAS-Inflammatory Mechanisms in Diabetes Uncovered by Tissue Imaging and Machine Learning, EPIAge, EPIAge)
Austrian Science Fund (F3012, W1226, P29203, P29262, P27893, P31727)
Karl-Franzens-Universität Graz (Unkonventionelle Forschung-InterFast and Fast4Health, Unkonventionelle Forschung-InterFast and Fast4Health)
Article History
Received: 19 September 2021
Accepted: 28 February 2022
First Online: 16 March 2022
Competing interests
: F.M. is scientific cofounder of Samsara Therapeutics, a company that develops novel pharmacological autophagy inducers. F.M. and T.E. have equity interests in and are advisors of TLL. The Longevity Labs GmbH. T.R.P. is scientific advisor for Novo Nordisk and The Longevity Labs (TLL). All other authors declare no conflict of interest.